- University of Helsinki
- Helsinki University Central Hospital
The purpose of this study is to demonstrate the ability of additive manufacturing, also known as 3D printing, to produce effective drug delivery devices and implants that are both identifiable, as well as traceable. Drug delivery devices can potentially be used for drug release in the direct vicinity of target tissues or the selected medication route in a patient-specific manner as required. The identification and traceability of additively manufactured implants can be administered through radiofrequency identification systems. The focus of this study is to explore how embedded medication and sensors can be added in different additive manufacturing processes. The concept is extended to biomaterials with the help of the literature. As a result of this study, a patient-specific drug delivery device can be custom-designed and additively manufactured in the form of an implant that can identify, trace, and dispense a drug to the vicinity of a selected target tissue as a patient-specific function of time for bodily treatment and restoration.
|Number of pages||14|
|Journal||JOURNAL OF FUNCTIONAL BIOMATERIALS|
|Publication status||Published - 29 Jun 2018|
|MoE publication type||A1 Journal article-refereed|
- additive manufacturing, 3D printing, biomaterials, parametric modeling, drug delivery systems, embedding, medicine, radiofrequency identification (RFID), object memory, Internet of things (IoT)